Target Engagement Biomarker

Target engagement biomarker quantitates pharmaceutical binding to intended molecular target validating mechanism engagement. Receptor occupancy measurement confirms target binding. Pathway activation indicates downstream effect. Dose-dependent engagement characterises saturation kinetics. Target selectivity assessment confirms specificity.

Regulatory submissions employ engagement evidence. Clinical outcomes correlate with engagement levels. Biomarker-driven dosing optimises engagement. Post-approval monitoring confirms engagement maintenance. Emerging imaging enables visualised engagement.